CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide

Molecular Genetics and Metabolism

Volumn 66, Issue 4, 1999, Pages 294-308

  Puranam, Kasturi L ^a   Guo, Wei Xing ^a   Qian, Wei Hua ^a   Nikbakht, Kave ^a   Boustany, Rose Mary ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Batten; Ceramide; Neurodegenerative disorder; Neuronal survival

Indexed keywords

CERAMIDE; CEROID; LIPOFUSCIN; STAUROSPORINE; VINCRISTINE;

APOPTOSIS; BRAIN ATROPHY; CELL GROWTH; CELL LINE; CELL SURVIVAL; CLINICAL FEATURE; CONFERENCE PAPER; NERVE DEGENERATION; NEURONAL CEROID LIPOFUSCINOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RETINITIS PIGMENTOSA;

EID: 0032799217     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1999.2834     Document Type: Conference Paper

References (44)

1. Boustany R-M, Alroy J, Kolodny E H. Clinical classification of neuronal ceroid lipofuscinosis subtypes. Am J Med Genet Suppl. 5:1988;47-58.
2. Boustany R-M, Kolodny E H. Neurological progress: The neuronal ceroid lipofuscinosis - A review. Rev Neurol (Paris). 145:1989;105-110.
3. Boustany R-M. Neurology of the neuronal ceroid lipofuscinosis. Am J Med Genet. 42:1992;533-535.
4. Boustany R-M, Filipek P. Seizures, depression and dementia. J Inher Metab Dis. 16:1993;252-255.
5. Boustany R-M. Batten disease or neuronal ceroid lipofuscinosis. 1996;Elsevier, Amsterdam. p. 671-700.
6. Lane S C, Jolly R D, Schmechel D E, Alroy J, Boustany R-M. Apoptosis is the mechanism of neurodegeneration in Batten disease. J Neurochem. 67:1996;677-683.
7. Puranam K, Qian W-H, Nikbakht K, Venable M, Obeid L, Hannun Y, Boustany R-M. Upregulation of Bcl-2 and elevation of ceramide in Batten disease. Neuropediatrics. 28:1997;37-41.
8. Cell. 82:1995;949-957.
9. Janes R W, Munroe P B, Mitchison H M, Gardiner R M, Mole S E, Wallace B A. A model for Batten disease protein CLN3: Functional implications from homology and mutations. FEBS Lett. 399:1996;75-77.
10. Altshul S F, Gish W, Miller W, Myers E W, Lipman D J. Basic local alignment search tool. J Mol Biol. 215:1990;403-410.
11. Mitchison H M, Munroe P B, O'Rawe A M, Taschner P E, de Vos N, Kremmidiotis G, Lensink I, Munk A C, D'Arigo K L, Anderson J W, Lerner T J, Moyzis R K, Callen D F, Breuning M H, Dogget N A, Gardiner R M, Mole S E. Genomic structure and complete nucleotide sequence of the Batten disease gene. Genomics. 40:1997;346-350.
12. Pleasure S J, Lee V M-Y. Ntera 2 cells: A human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J Neurol Res. 35:1993;585-602.
13. Howard M K, Burke L C, Mailhos C, Pizzey A, Gilbert C S, Lawson W D, Collins M KL, Thomas N SB, Latchman D S. Cell cycle arrest of proliferating neuronal cells by serum starvation can result in either apoptosis or differentiation. J Neurochem. 60:1993;1783-1791.
14. Kulkarni G V, McCulloch C A. Serum deprivation induces apoptotic cell death in a subset of Balb/c 3T3 fibroblasts. J Cell Sci. 107:1994;1169-1179.
15. Obeid L M, Linardic C M, Karolak L A, Hannun Y A. Programmed cell death induced by ceramide. Science. 259:1993;1769-1771.
16. Walker P R, Smith C, Youdale T, Leblanc J, Whitfield J F, Sikorska M. Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res. 51:1991;1078-1085.
17. Bertand R, Solary E, O'Connor P, Kohn K W, Pommier Y. Induction of a common pathway of apoptosis by staurosporine. Exp Cell Res. 211:1994;314-321.
18. Stoll C, Borgaonkar D S, Levy J M. Effect of vincristine on sister chromatid exchanges of normal human lymphocytes. Cancer Res. 36:1976;2710-2713.
19. Hannun Y A, Obeid L M. Ceramide: An intracellular signal for apoptosis. Trends Biochem Sci. 20:1995;73-77.
20. Alnemri E S, Livingston D J, Nicholson D W, Salvesen G, Thornberry N A, Wong W W, Yuan J. Human ICE/CED-3 protease nomenclature. Cell. 87:1996;171.
21. Martin S J, Green D R. Protease activation during apoptosis. Cell. 82:1995;349-352.
22. Kaufmann S, Desnoyers S, Ottaviano Y, Davidson N E, Poirier G G. Specific proteolytic cleavage of poly (ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Res. 53:1993;3976-3985.
23. Smyth M J, Perry D K, Zhang J, Poirier G G, Hannun Y A, Obeid L M. prICE: A downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2. Biochem J. 316:1996;25-28.
24. Perry D K, Smyth M J, Wang H-G, Reed J C, Duriez P, Poirier G G, Obeid L M, Hannun Y A. Bcl-2 acts upstream of the PARP protease and prevents its activation. Cell Death Differ. 4:1997;29-33.
25. Andersson S, Davis D L, Dahlback H, Jornvall H, Russell D W. Cloning, structure and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid synthetic enzyme. J Biol Chem. 264:1989;8222-8229.
26. Fieck A, Wyborski D L, Short J M. Modification of the E. Coli Lac repressor for expression in eukaryotic cells: Effects of nuclear signal sequences on protein activity and nuclear accumulation. Nucleic Acids Res. 20:1992;1785-1791.
27. Estus S, Zaks W J, Freeman R S, Gruda M, Bravo R, Johnson E M Jr. Altered gene expression in neurons during programmed cell death. J Cell Biol. 127:1994;1717-1727.
28. Schmitz, G, Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase, Anal Biochem, 192, 222, 231.
29. Bligh E G, Dyer W J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 37:1959;911-917.
30. Zhang J, Alter N, Obeid L M, Hannun Y A. Ceramide mediated apoptosis is inhibited by Bcl-2. Proc Natl Acad Sci USA. 93:1996;5325-5328.
31. Harmon B V, Takano Y S, Winterford M, Potten C S. Cell death induced by vincristine in the intestinal crypts of mice and in human Burkitt's lymphoma cell lines. Cell Prolif. 25:1992;523-536.
32. Arends M J, Morris R G, Wyllie A H. Apoptosis: The role of the endonuclease. Am J Pathol. 136:1990;593-608.
33. Rosenbaum D M, Michaelson M, Batter D K, Doshi P, Kessler J A. Evidence for hypoxia induced programmed cell death of neurons. Ann Neurol. 36:1994;864-870.
34. Griffith T S, Brunner T, Fletcher S M, Green D R, Ferguson T A. Fas-ligand induced apoptosis as a mechanism of immune privilege. Science. 270:1995;1189-1192.
35. Griffith T S, Yu X, Herndon J M, Green D R, Ferguson T A. CD-95 induced apoptosis of lymphocytes in an immune privileged site induces immunologic tolerance. Immunity. 5:1996;7-16.
36. White E. Life, death, and the pursuit of apoptosis. Genes Dev. 10:1996;1-15.
37. Hannun Y A. Functions of ceramide in coordinating cellular responses to stress. Science. 274:1996;1855-1859.
38. Liu X, Kim C N, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell. 86:1996;147-157.
39. Rena L A, Fuls Z, Kolesnick R. Stress induced apoptosis and the sphingomyelin pathway. Biochem Pharmacol. 53:1997;615-621.
40. Cleary M L, Sklar J. Nucleotide sequence of a t(14:18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA. 82:1985;7439-7443.
41. Cleary M L, Smith S D, Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from t(14;18) translocation. Cell. 47:1986;19-28.
42. Garcia I, Matinar I, Tsujimoto Y, Martinou J C. Prevention of programmed cell death of sympathetic neurons by the bcl-2 protoonocogene. Science. 258:1992;302-304.
43. Zhong L-T, Sarafian T, Kane D J, Charles A C, Mah S P, Edwards R H, Bredesen D E. Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA. 90:1993;4533-4537.
44. Sleat D E, Lackland H, Liu C G, Sohar I, Pullarkat R K, Lobel P. Association of mutations in a lysosomal protein with classical late infantile neuronal ceroid lipofuscinosis. Science. 277:1997;1802-1805.